Progressive Relaxation Exercise on Pain, Anxiety and Patient Satisfaction
Launched by TC ERCIYES UNIVERSITY · Mar 6, 2025
Trial Information
Current as of May 10, 2025
Completed
Keywords
ClinConnect Summary
This study aimed to determine the effect of progressive relaxation exercise (PRE) applied to patients undergoing percutaneous coronary intervention (PCI) on pain, anxiety and patient satisfaction related to femoral sheath removal. This single-center, prospective, randomized controlled trial was completed with a total of 70 patients, 35 in each of the intervention and control groups. Data were collected using the Patient Information Form, Visual Analogy Scale and State-Trait Anxiety Inventory. Patients in the intervention group performed PRE for 20 minutes before femoral sheath removal. The ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • able to speak and understand Turkish,
- • over 18 years of age,
- • intervened in the femoral region,
- • with only one catheter in the femoral region,
- • without vision and hearing problems,
- • undergoing angiography procedure for the first time,
- • with normal vital signs,
- • who have not been administered analgesics for any reason prior to sheath removal after the procedure,
- • patients who volunteered to participate in the study were included in the study.
- Exclusion Criteria:
- • patients with chronic pain using transdermal patches,
- • patients with impaired time and place orientation,
- • patients with psychiatric disorders.
About Tc Erciyes University
TC Erciyes University is a leading academic institution in Turkey, dedicated to advancing medical research and healthcare through innovative clinical trials. With a strong emphasis on scientific excellence and collaboration, the university leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies aimed at improving patient outcomes. Committed to ethical standards and regulatory compliance, TC Erciyes University fosters a research environment that promotes the development of new therapies and interventions, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Talas, Kayseri, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported